Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1

American Journal of Physiology

Volumn 272, Issue 6 PART 2, 1997, Pages

  Yue Hua, L I ^a   Fan, Jie ^a   Lang, Charles H ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Corticosterone; Insulin like growth factor binding proteins; Insulin like growth factor i; Messenger ribonucleic acid; Mifepristone; Rats; RU 486; Surgical trauma

Indexed keywords

EID: 33745368882     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adamo, M. L., H. Ben-Hur, C. T. Roberts, and D. LeRoith. Regulation of start-site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting and diabetes. Mol. Endocrinol. 5:1677-1686,1991.
2. Arany, E., A. J. Strain, M. J. Hube, I. D. Phillips, and D. J. Hill. Interactive effects of nutrients and hormones on the expression of insulin-like growth factor binding protein-1 (IG-FBP-1) mRNAand peptide, and IGF-I release from isolated adult rat hepatocytes. J. Cell. Physiol. 155: 426-435,1993.
3. Baxter, R. C. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Pediatr. Scared. 372, Suppl.: 107-114, 1991.
4. Cannon, J. G., J. S. Friedberg, J. A. Gelfand, R. G. Tompkins, J. F. Burke, and C. A. Dinarello. Circulating interleukin-1beta; and tumor necrosis factor-alpha concentrations after burn injury in humans. Crit. Care Med. 20:1414-1419, 1992.
5. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extract. Anal. Biochem. 162: 156-159, 1986.
6. Conover, C. A., G. D. Divertie, and P. D. K. Lee. Cortisol increases plasma insulin-like growth factor binding protein in humans. Acta Endocrinol. 128: 140-143, 1993.
7. Dardevet, D., C. Sornet, D. Attaix, V. E. Baracos, and J. Grizard. Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats. Endocrinology 134: 1475-1484, 1994.
8. Ertel, W., M. H. Morrison, P. Wang, Z. F. Ba, A. Ayala, and I. H. Chaudry. The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin, and interleukins. Ann. Surg. 214: 141-148, 1991.
9. Fan, J., D. Char, G. J. Bagby, M. C. Gelato, and C. H. Lang. Regulation of insulin-like growth factor (IGF)-I and IGF-binding proteins by tumor necrosis factor. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R1204-R1212,1995.
10. Fan, J., D. Char, A. J. Kolasa, W. Pan, S. R. Maitra, C. S. Patlak, Z. Spolarics, M. C. Gelato, and C. H. Lang. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E33-E42,1995.
11. Fan, J., Y. H. Li, G. J. Bagby, and C. H. Lang. Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody. Shock 4: 21-26, 1995.
12. Fan, J., P. E. Molina, M. C. Gelato, and C. H. Lang. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134:1685-1692,1994.
13. Fan, J., M. M. Wojnar, M. Theodorakis, and C. H. Lang. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide, and IGF-binding proteins by interleukin-1. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R621-R629, 1996.
14. Frost, R. A., J. Fuhrer, R. Steigbigel, P. Mariuz, C. H. Lang, and M. C. Gelato. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin. EndocrinoL 44: 501-514, 1996.
15. Hall-Angeras, M., U. Angeras, O. Zamir, P.-O. Hasselgren, and J. E. Fischer. Effect of the glucocorticoid receptor antagonist RU38486 on muscle protein breakdown in sepsis. Surgery 109: 468-473, 1991.
16. Hossenlopp, P., D. Seurin, B. Segonia-Quinson, S. Hardouin, and M. Binoux. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding sites. Anal. Biochem. 154: 138-143, 1986.
17. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
18. Lang, C. H., G. J. Bagby, and J. J. Spitzer. Glucose kinetics following lethal and sublethal doses of endotoxin. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R471-R478, 1984.
19. Lang, C. H., J. Fan, R. Cooney, and T. C. Vary. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E430-E437, 1996.
20. Lang, C. H., J. Fan, R. A. Frost, M. C. Gelato, Y. Sakurai, D. N. Herndon, and R. R. Wolfe. Regulation of the insulin-like growth factor system by insulin in burn patients. J. Clin. Endocrinol. Metab. 81: 2474-2480, 1996.
21. Lazar, G., E. Duda, and G. Lazar. Effect of RU 38486 on TNF production and toxicity. FEBS Lett. 308: 137-140, 1992.
22. Lee, P. D. K., C. A. Conover, and D. R. Powell. Regulation and function of insulin-like growth factor-binding protein-1. Proc. Soc. Exp. Biol. Med. 204: 4-29,1993.
23. Luo, J., R. E. Reid, and L. J. Murphy. Dexamethasone increases hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) mRNAand serum IGFBP-1 concentrations in the rat. Endocrinology 127: 1456-1462, 1990.
24. Mao, J., W. Regelson, and M. Kalimi. Molecular mechanism of RU 486 action: a review. Mol. Cell. Biochem. 109: 1-8, 1992.
25. Morrow, L. E., J. L. McClellan, C. A. Conn, and M. J. Kluger. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R1010-R1016, 1993.
26. Pao, C.-L, P. K. Farmer, S. Begovic, B. C. Villafuerte, G.-J. Wu, D. G. Robertson, and L. S. Phillips. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein 1 gene transcription by hormones and provision of amino acids in rat hepatocytes. Mol. Endocrinol. 7: 1561-1568, 1993.
27. Ross, R. J. M., J. P. Miell, J. M. P. Holly, H. Maheshwari, M. Norman, A. F. Abdulla, and C. R. Buchanan. Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients. Clin. Endocrinol. 35: 361-367,1991.
28. Samstein, B., M. L. Hohnes, J. Fan, R. A. Frost, M. C. Gelato, and C. H. Lang. IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-l production. Biochem. Biophys. Res. Commun. 228: 611-615, 1996.
29. Siaud, P., I. Assenmacher, and G. Barbanel. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R164-R170, 1994.
30. Unterman, T. G., and L. S. Phillips. Glucocorticoid effect on somatomedins and somatomedin inhibitors. J. Clin. Endocrinol. Metab. 61: 618-628, 1985.
31. Wojnar, M. M., J. Fan, R. A. Frost, M. C. Gelato, and C. H. Lang. Alterations in the insulin-like growth factor system in trauma patients. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R970-R977, 1995.
32. Zamir, O., P.-O. Hasseigren, D. von Allmen, and J. E. Fischer. The effect of interleukin-1α and the glucocorticoid receptor blocker RU38486 on total and myofibrillar protein breakdown in skeletal muscle. J. Surg. Res. 50: 579-583, 1991.